← Back to Search

Behavioral Intervention

Cognitive + Motivational Enhancement for Early Psychosis

N/A
Recruiting
Led By Piper Meyer-Kalos, PhD
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights

Study Summary

This trial will assess a mobile intervention program to target cognitive functioning & motivated behavior for early psychosis. Participants will be recruited from early psychosis CSC programs in the US & tested remotely at home on their own devices.

Who is the study for?
This trial is for individuals aged 18-40 with early psychosis or related conditions, enrolled in a specialty care clinic. They must be stable (no recent hospitalization or active suicidal thoughts), have access to a smartphone and computer, speak English fluently, and have an IQ above 70.Check my eligibility
What is being tested?
The study tests a mobile intervention program targeting cognition and motivation over 12 weeks against usual treatment. Participants will use the PRIME App and cognitive training exercises at home, with follow-ups at 6 and 12 months post-training.See study design
What are the potential side effects?
Since this trial involves cognitive training and app-based interventions rather than medication, typical medical side effects are not expected. However, participants may experience fatigue or stress from regular engagement with the exercises.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Behavioral Inhibition and Activation Scale (BIS/BAS) - BAS Drive Score
Change in Behavioral Inhibition and Activation Scale (BIS/BAS) - BAS Fun Seeking Score
Change in Behavioral Inhibition and Activation Scale (BIS/BAS) - BAS Reward Responsiveness Score
+8 more
Secondary outcome measures
COMPASS-10
Other outcome measures
BrainHQ Cognitive Training Performance Data
Tolerability of BrainHQ Cognitive Training & PRIME

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Cognitive Training plus Personalized Real-Time Intervention for Motivational EnhancementExperimental Treatment3 Interventions
The Mobile Intervention. 20 hours of training consisting of 10 hours of cognitive training exercises plus 10 hours of social cognitive training exercises will be delivered over the course of 12 weeks. Participants will also engage in the PRIME app on a smart phone and will receive personalized support from a motivation enhancement coach.
Group II: Treatment as UsualActive Control1 Intervention
Participants will be treated as usual in their early psychosis CSC program and will not complete cognitive training or use the Personalized Real-Time Motivational Enhancement App.

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,786 Previous Clinical Trials
2,689,509 Total Patients Enrolled
University of MinnesotaLead Sponsor
1,381 Previous Clinical Trials
1,588,775 Total Patients Enrolled
Piper Meyer-Kalos, PhDPrincipal InvestigatorUniversity of Minnesota Department of Psychiatry and Behavioral Sciences
1 Previous Clinical Trials
6 Total Patients Enrolled

Media Library

Cognitive and Social Cognitive Training (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05877716 — N/A
Cognitive and Social Cognitive Training (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05877716 — N/A
Major Depressive Disorder Clinical Trial 2023: Cognitive and Social Cognitive Training Highlights & Side Effects. Trial Name: NCT05877716 — N/A
Major Depressive Disorder Research Study Groups: Treatment as Usual, Cognitive Training plus Personalized Real-Time Intervention for Motivational Enhancement

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria must I meet to qualify for participation in this experiment?

"This clinical trial is accepting 200 qualified candidates who have been diagnosed with bipolar disorder and are between the ages of 15-40."

Answered by AI

Are participants aged 80 or younger being enrolled for this experiment?

"The parameters for patient enrollment in this clinical trial stipulate that the minimum age is 15 and the maximum age 40."

Answered by AI

What is the current size of the cohort participating in this trial?

"Affirmative, data hosted on clinicaltrials.gov indicates that this trial is actively searching for suitable participants. It was initially posted May 1st 2023 and has since been updated as of May 17th 2023. The study needs 200 volunteers at a single location to join the medical trial."

Answered by AI

Is there availability to join this experiment?

"Affirmative. According to the data posted on clinicaltrials.gov, this medical investigation is currently accepting patients for participation. It was initially published in May 1st 2023 and updated as recently as May 17th of the same year. 200 people are being sought from one clinic location."

Answered by AI

Who else is applying?

What state do they live in?
Minnesota
What site did they apply to?
University of Minnesota Department of Psychiatry & Behavioral Sciences
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

Recent research and studies
clinicaltrials.govStudy
EPI-MINN: Targeting Cognition and Motivation - National
2023. "EPI-MINN: Targeting Cognition and Motivation - National". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05877716.
All > Bipolar Disorder
~112 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top